Radioactive steroids that are labelled with gamma-emitting isotopes are unusual probes of hormone action. When labelled with radioiodine, such biologically active steroid hormones are extremely sensitive ligands for the study of steroid receptors and they make possible the external imaging of human tumors that contain steroid hormone receptors. The first biologically active gamma-emitting steroid hormone 16alpha-[125I]iodo-17beta-estradiol was synthesized in this laboratory. It and our modified analog, 11beta-methoxy- 16alpha-[125I]iodo-17beta-estradiol, have been used extensively for the sensitive detection and quantification of the estrogen receptor. We are synthesizing other analogs of 16alpha-iodo-17beta-estradiol which may have superior estrogen receptor properties and will test them for in vivo concentration in estrogen target tissues. We will label the best of these analogs with [123I] for in vivo imaging of estrogen receptor containing human breast cancer. Recently we have succeeded in the synthesis of a long sought for steroidal probe, a gamma-emitting androgen, E-17alpha-(2'-iodovinyl-4,9-estradiene- 17beta-ol-3-one, E-MIVNT. We have synthesized E-MIVNT labelled with [125I] in carrier free form (2,200 Ci/mmol) and have found that is binds to the androgen receptor with very affinity and low nonspecific binding. E-[125I]MIVNT binds only poorly if it at all to other steroid receptors. We are testing E-MIVNT and other 17alpha- iodovinyl analogs for their androgenic potency, metabolism and ability to concentrate in vivo in tissues that contain the androgen receptor. The most suitable of these androgens will be synthesized with [123I] and used for imaging studies in males with prostatic cancer. We will synthesize the [125I]androgen and estrogen as probes in collaborative studies of androgen and estrogen action in the brain. We will synthesize an [123I]labelled glucocorticoid for Single Photon Emission Computed Tomography of glucocorticoid receptor rich regions of the primate brain. Using this ligand we will attempt to determine in vivo the kinetics of glucocorticoid interaction with its receptor. This [123I]glucocorticoid would provide a probe for investigating defects in the brain glucocorticoid receptor, which have been hypothesized to be involved in several disorders, including depression and stress. In our synthesis of gamma-emitting estrogens we have searched for regions of the steroid nucleus that are both accessible to chemical reactions and transparent to receptor interactions when bulky groups are substituted. In these studies we have found compounds that are unique estrogens and antiestrogens. In addition we have uncovered analogs that are active estrogens but extremely labile. We are synthesizing other derivatives of these steroids which may have important therapeutic actions for use as locally active estrogens in the menopause.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037799-11
Application #
2089431
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1984-08-01
Project End
1996-01-31
Budget Start
1995-02-15
Budget End
1996-01-31
Support Year
11
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Yale University
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Bowlby, Deborah A; Brown, Theodore J; Hochberg, Richard B et al. (2016) In vitro Autoradiographic Analysis of Regional Changes in Estrogen Receptor Alpha in the Brains of Cycling Female Rats. Neuroendocrinology 103:538-51
Hanson, Robert N; Hua, Edward; Hendricks, J Adam et al. (2012) Synthesis and evaluation of 11?-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists. Bioorg Med Chem 20:3768-80
Hanson, Robert N; McCaskill, Emmett; Tongcharoensirikul, Pakamas et al. (2012) Synthesis and evaluation of 17?-(dimethylphenyl)vinyl estradiols as probes of the estrogen receptor-? ligand binding domain. Steroids 77:471-6
Olmsted, Sandra L; Tongcharoensirikul, Pakamas; McCaskill, Emmett et al. (2012) Synthesis and evaluation of 17?-E-20-(heteroaryl)norpregn-1,3,5(10),20 tetraene-3,17?-diols [17?-(heteroaryl)vinyl estradiols] as ligands for the estrogen receptor-? ligand binding domain (ER?-LBD). Bioorg Med Chem Lett 22:977-9
Haddad, Terra; Gershman, Rachel; Dilis, Robert et al. (2012) Synthesis and evaluation of 4-(substituted styryl/alkenyl)-3,5-bis(4-hydroxyphenyl)-isoxazoles as ligands for the estrogen receptor. Bioorg Med Chem Lett 22:5999-6003
Hanson, Robert N; Kirss, Rein; McCaskill, Emmett et al. (2012) Targeting the estrogen receptor with metal-carbonyl derivatives of estradiol. Bioorg Med Chem Lett 22:1670-3
Hanson, Robert N; Hua, Edward; Labaree, David et al. (2012) Convergent synthesis of a steroidal antiestrogen-mitomycin C hybrid using ""click"" chemistry. Org Biomol Chem 10:8501-8
Nettles, Kendall W; Bruning, John B; Gil, German et al. (2008) NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat Chem Biol 4:241-7
McCarthy, Thomas L; Hochberg, Richard B; Labaree, David C et al. (2007) 3-ketosteroid reductase activity and expression by fetal rat osteoblasts. J Biol Chem 282:34003-12
Kahn, Michael G C; Konde, Emmanuel; Dossou, Francis et al. (2006) Microwave-enhanced nucleophilic fluorination in the synthesis of fluoropyridyl derivatives of [3,2-c]pyrazolo-corticosteroids, potential glucocorticoid receptor-mediated imaging agents. Bioorg Med Chem Lett 16:3454-8

Showing the most recent 10 out of 53 publications